title: Asthenoazoospermia in patients receiving anti-tumour necrosis factor {alpha} agents.
authors.forename: G La
authors.initials: GL
authors.lastname: Montagna
authors.forename: D
authors.initials: D
authors.lastname: Malesci
authors.forename: R
authors.initials: R
authors.lastname: Buono
authors.forename: G
authors.initials: G
authors.lastname: Valentini
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D009845:Oligospermia / Q000139:chemically induced*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab